IP Library › Assignment 054661/0446
Patent Assignment
Reel/Frame 054661/0446

Assignment of Assignor's Interest

Recorded: 2020-12-16 Pages: 8
Assignor
Assignee
EIKONIZO THERAPEUTICS, INC.
LABCENTRAL, 700 MAIN STREET NORTH, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (2)
Metalloenzyme Inhibitor Compounds
Application: 15/917,555 →
Publication: US 2018/0256572
Metalloenzyme Inhibitor Compounds
Application: 16/518,279 →
Publication: US 2020/0171028
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 3, 2018
From: VPS-3, INC.
To: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
Reel/Frame 046552/0282 →
Assignment of Assignor's Interest Aug 3, 2018
From: YATES, CHRISTOPHER M.
To: VPS-3, INC.
Reel/Frame 046552/0181 →
Change of Name Dec 21, 2018
From: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 047978/0330 →
Assignment of Assignor's Interest Feb 18, 2020
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: VIAMET PHARMACEUTICALS HOLDINGS, LLC
Reel/Frame 051845/0718 →
Corrective Assignment to Correct the Correct Assignee Street Address Previously Recorded at Reel: 05145 Frame: 0718. Assignor(S) Hereby Confirms the Assignment. Feb 21, 2020
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: VIAMET PHARMACEUTICALS HOLDINGS, LLC
Reel/Frame 051986/0472 →
Assignment of Assignor's Interest Sep 24, 2020
From: YATES, CHRISTOPHER M.
To: VPS-3, INC.
Reel/Frame 053867/0375 →
Assignment of Assignor's Interest Sep 24, 2020
From: VPS-3, INC.
To: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
Reel/Frame 053867/0470 →
Change of Name Sep 24, 2020
From: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 053867/0857 →
Assignment of Assignor's Interest Dec 16, 2020
From: YATES, CHRISTOPHER M.
To: VIAMET PHARMACEUTICALS HOLDINGS, LLC
Reel/Frame 054670/0484 →
Assignment of Assignor's Interest Jan 26, 2021
From: YATES, CHRIS
To: VPS-3, INC.
Reel/Frame 055037/0850 →
Assignment of Assignor's Interest Mar 30, 2021
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: VIAMET PHARMACEUTICALS HOLDINGS, LLC
Reel/Frame 055773/0125 →